ACOG 委员会意见第 770 号摘要:疑似子宫肌瘤的子宫粉碎术
该委员会意见指出,对疑似症状性子宫肌瘤行子宫或肌瘤开放(无 containment)粉碎术可能扩散未疑及的平滑肌肉瘤,术前应评估子宫体恶性肿瘤风险,恶性肿瘤禁忌粉碎。应与患者共同决策并知情同意,说明各术式及粉碎术的风险获益与替代方案。
要点
- 开放(无 containment)粉碎术可能扩散未疑及的平滑肌肉瘤,导致预后恶化。
- 恶性肿瘤禁忌行粉碎术,术前应评估以识别恶性肿瘤,但平滑肌肉瘤无法可靠术前诊断。
- 开腹子宫切除或肌瘤剔除可降低未诊断平滑肌肉瘤扩散风险,但较微创途径并发症发生率更高。
核心结论
- 粉碎术是缩小子宫或肌瘤以便经小切口或腹腔镜器械取出的手术技术。
- 开放(无 containment)粉碎术因可能扩散未疑及的平滑肌肉瘤而受到审视。
- 恶性肿瘤禁忌行粉碎术,术前应评估以识别恶性肿瘤,但平滑肌肉瘤无法可靠术前诊断。
- 开腹子宫切除或肌瘤剔除可降低未诊断平滑肌肉瘤扩散风险,但较微创途径并发症发生率更高。
- 妇产科医生与患者应共同决策并知情同意,说明各术式及粉碎术的风险获益与替代方案。
研究设计与样本
- 美国妇产科医师学会(ACOG)委员会意见第 770 号摘要。
关键数值与推荐
- 恶性肿瘤禁忌行粉碎术。
- 术前应评估以识别恶性肿瘤,但平滑肌肉瘤无法可靠术前诊断。
- 开放(无 containment)粉碎术可能扩散未疑及的平滑肌肉瘤,导致预后可能恶化。
- 开腹子宫切除或肌瘤剔除可降低未诊断平滑肌肉瘤扩散风险,但较微创途径并发症发生率更高。
- 应与患者共同决策并知情同意,说明各术式及粉碎术的风险获益与替代方案。
临床怎么用
- 考虑开放粉碎术前应评估患者是否存在子宫体恶性肿瘤风险增加。
- 恶性肿瘤禁忌行粉碎术,术前应评估以识别恶性肿瘤。
- 妇产科医生与患者应共同决策并知情同意,说明各术式及粉碎术的风险获益与替代方案。
局限性
- 平滑肌肉瘤无法可靠术前诊断,因此疑似肌瘤患者可能存在经粉碎术扩散的恶性肿瘤。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Morcellation is a surgical technique used to reduce the size of the uterus or myomas by creating smaller pieces to allow the tissue to be removed through small incisions or with laparoscopic instruments. Open (uncontained) morcellation of the uterus and myomas has been scrutinized because of the possible spread of an unsuspected leiomyosarcoma while using a power morcellator during a hysterectomy or myomectomy for presumed symptomatic uterine leiomyomas. Before considering open morcellation of the uterus, a woman should be evaluated to determine if she is at increased risk of malignancy of the uterine corpus. Morcellation of a malignancy is contraindicated, and women should be evaluated preoperatively to identify malignancy. However, leiomyosarcoma cannot be reliably diagnosed preoperatively; thus, there is a risk that a woman with a presumed leiomyoma may have a malignancy that may be spread through morcellation, leading to a potentially worsened prognosis. Although an abdominal hysterectomy or myomectomy may reduce the chance of spreading cancer cells in women with undiagnosed leiomyosarcoma, it is associated with increased morbidity when compared with minimally invasive approaches. The obstetrician-gynecologist and patient should engage in shared decision making, including informed consent explaining the risks and benefits of each approach to surgery for presumed leiomyomas, the risks and benefits of morcellation, and alternatives to morcellation.
引用
- ACOG Committee Opinion No. 770 Summary: Uterine Morcellation for Presumed Leiomyomas. Obstet Gynecol. 2019. PMID: 30801469. doi:10.1097/AOG.0000000000003127
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。